KKR Partners with Duke Rohlen to Create Medical Device Platform

MENLO PARK, Calif.–(BUSINESS WIRE)– KKR, a leading global investment firm, and Duke Rohlen, a 20-year medical device veteran, today announced the formation of Zeus Health (“Zeus”), a $100 million platform focused on investing in and operating a portfolio of emerging medical device companies. Zeus marks the continuation of a long-standing relationship between KKR and Mr. Rohlen. Throughout …

Read Previous

Asda acquisition by TDR Capital, Issa Brothers on track to complete in 1H21

Read Next

Permira appoints senior adviser amid healthcare push

Most Popular

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.